NasdaqGS:HSICHealthcare
Henry Schein Sales Surge And CEO Stock Sale Refocus Investor Attention
Henry Schein (NasdaqGS:HSIC) reported its strongest sales growth in 15 quarters, highlighting a shift in recent operating momentum.
The company introduced a new multi year value creation plan that outlines its priorities for the coming years.
A large stock sale by the CEO followed these announcements, drawing attention to insider activity at the company.
Henry Schein enters this news cycle with its shares at $80.17 and a value score of 5, reflecting how the market has been pricing the...